DHX9 and cancer: DEAH box helicase 9 (DHX9), also known as nuclear DNA helicase II, has been shown to constitute a bidirectional regulatory mode in adenosine-to-inosine (A-to-I) editing, which is partially responsible for the dysregulation of editing spectrum in cancer.